Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


2 Acta Psychiatr Scand
1 Clin Neuropharmacol
1 J Clin Psychiatry
1 Mol Psychiatry
1 Neuropsychopharmacology
1 Neurosci Lett
1 Psychiatry Res
1 Psychol Med
12 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Psychiatr Scand

  1. FUJIWARA M, Yamada Y, Shimazu T, Kodama M, et al
    Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial.
    Acta Psychiatr Scand. 2021 Jul 9. doi: 10.1111/acps.13348.
    PubMed         Abstract available

  2. SUAREZ-PINILLA P, Suarez-Pinilla M, Setien-Suero E, Ortiz-Garcia de la Foz V, et al
    Stability of schizophrenia diagnosis in a ten-year longitudinal study on first episode of non-affective psychosis: conclusions from the PAFIP cohort.
    Acta Psychiatr Scand. 2021 Jul 6. doi: 10.1111/acps.13344.
    PubMed         Abstract available

    Clin Neuropharmacol

  3. ALAVI S, Darharaj M, Bilehsavar SH, Amini M, et al
    Successful Use of Minocycline for the Treatment of Methamphetamine-Induced Psychosis and Cognitive Impairments: An Open-Label Case Series.
    Clin Neuropharmacol. 2021;44:126-131.
    PubMed         Abstract available

    J Clin Psychiatry

  4. BALLARD C, Aarsland D
    Relieving Caregiver Burden Through Evidence-Based Treatment for Dementia-Related Psychosis.
    J Clin Psychiatry. 2021;82.
    PubMed         Abstract available

    Mol Psychiatry

  5. HEURICH M, Focking M, Mongan D, Cagney G, et al
    Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis.
    Mol Psychiatry. 2021 Jul 5. pii: 10.1038/s41380-021-01197.
    PubMed         Abstract available


  6. FERRARELLI F, Phillips ML
    PFC neuromodulation with theta burst stimulation to impact behavior and neural network activity in schizophrenia and bipolar disorder.
    Neuropsychopharmacology. 2021 Jul 7. pii: 10.1038/s41386-021-01086.

    Neurosci Lett

  7. VALES K, Holubova K
    Minireview: Animal model of schizophrenia from the perspective of behavioral pharmacology: effect of treatment on cognitive functions.
    Neurosci Lett. 2021 Jul 2:136098. doi: 10.1016/j.neulet.2021.136098.
    PubMed         Abstract available

    Psychiatry Res

  8. MUNOZ-SAMONS D, Tor J, Rodriguez-Pascual M, Alvarez-Subiela X, et al
    Recent stressful life events and stress sensitivity in children and adolescents at clinical risk for psychosis.
    Psychiatry Res. 2021;303:114017.
    PubMed         Abstract available

    Psychol Med

  9. JOHNSON EC, Kapoor M, Hatoum AS, Zhou H, et al
    Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder.
    Psychol Med. 2021 Jul 7:1-9. doi: 10.1017/S003329172100266.
    PubMed         Abstract available

    Schizophr Res

  10. OREPIC P, Rognini G, Kannape OA, Faivre N, et al
    Sensorimotor conflicts induce somatic passivity and louden quiet voices in healthy listeners.
    Schizophr Res. 2021;231:170-177.
    PubMed         Abstract available

  11. NASKAR C
    Understanding the effect of various factors on clozapine serum levels in Indian population.
    Schizophr Res. 2021;231:178.

  12. BANEA OC, Bandeira Dos Santos LG, Marcu S, Stefannson SB, et al
    Network signatures of rTMS treatment in patients with schizophrenia and auditory verbal hallucination during an auditory-motor task using HD-EEG.
    Schizophr Res. 2021 Jun 30. pii: S0920-9964(21)00214.

  13. FUSAR-POLI P, Salazar de Pablo G
    Antipsychotics and Attenuated Psychosis Syndrome: Transdiagnostic assessment and discontinuation strategies.
    Schizophr Res. 2021 Jun 30. pii: S0920-9964(21)00242.

  14. IGATA R, Tesen H, Konishi Y, Ikenouchi A, et al
    Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings.
    Schizophr Res. 2021 Jul 1. pii: S0920-9964(21)00253.

  15. SALGADO-PINEDA P, Fuentes-Claramonte P, Spanlang B, Pomes A, et al
    Neural correlates of disturbance in the sense of agency in schizophrenia: An fMRI study using the 'enfacement' paradigm.
    Schizophr Res. 2021 Jul 1. pii: S0920-9964(21)00243.
    PubMed         Abstract available

  16. BURKHARDT E, Berger M, Yolken RH, Lin A, et al
    Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample.
    Schizophr Res. 2021;233:24-30.
    PubMed         Abstract available

  17. O'DONOGHUE B, Castagnini E, Langstone A, Mifsud N, et al
    Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions.
    Schizophr Res. 2021;233:31-33.

  18. HOY KE, Coyle H, Gainsford K, Hill AT, et al
    Investigating neurophysiological markers of impaired cognition in schizophrenia.
    Schizophr Res. 2021;233:34-43.
    PubMed         Abstract available

  19. GROSSMAN MJ, Bowie CR
    Money talks: The influence of extrinsic motivators on social cognition in early episode psychosis.
    Schizophr Res. 2021;233:52-59.
    PubMed         Abstract available

  20. KHACHADOURIAN V, Zaks N, Lin E, Reichenberg A, et al
    Advanced paternal age and risk of schizophrenia in offspring - Review of epidemiological findings and potential mechanisms.
    Schizophr Res. 2021;233:72-79.
    PubMed         Abstract available

  21. MISAWA F, Okumura Y, Takeuchi Y, Fujii Y, et al
    Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan.
    Schizophr Res. 2021;231:42-46.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.